Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy.
Pfeffer TJ, Mueller JH, Haebel L, Erschow S, Yalman KC, Talbot SR, Koenig T, Berliner D, Zwadlo C, Scherr M, Hilfiker-Kleiner D, Bauersachs J, Ricke-Hoch M.
Pfeffer TJ, et al.
ESC Heart Fail. 2023 Feb;10(1):465-477. doi: 10.1002/ehf2.14210. Epub 2022 Oct 27.
ESC Heart Fail. 2023.
PMID: 36300679
Free PMC article.
AIMS: Peripartum cardiomyopathy (PPCM) is a rare heart disease, occurring in previously heart-healthy women during the last month of pregnancy or the first months after delivery due to left ventricular (LV) systolic dysfunction. ...Inhibition of prolactin secretion …
AIMS: Peripartum cardiomyopathy (PPCM) is a rare heart disease, occurring in previously heart-healthy women during the last mo …